Apellis Pharmaceuticals
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell APLS and other ETFs, options, and stocks.About APLS
Apellis Pharmaceuticals, Inc. is a commercial-stage biopharmaceutical company, which engages in the discovery, development, and commercialization of novel therapeutic compounds to treat diseases with high unmet needs. Its products include EMPAVELI and SYFOVRE.
APLS Key Statistics
Stock Snapshot
As of today, Apellis Pharmaceuticals(APLS) shares are valued at $19.93. The company's market cap stands at 2.52B, with a P/E ratio of 68.95.
On 2025-11-06, Apellis Pharmaceuticals(APLS) stock traded between a low of $19.93 and a high of $20.64. Shares are currently priced at $19.93, which is +0.0% above the low and -3.4% below the high.
Apellis Pharmaceuticals(APLS) shares are trading with a volume of 3.08M, against a daily average of 3.98M.
In the last year, Apellis Pharmaceuticals(APLS) shares hit a 52-week high of $35.72 and a 52-week low of $16.10.
In the last year, Apellis Pharmaceuticals(APLS) shares hit a 52-week high of $35.72 and a 52-week low of $16.10.
APLS News
Wolfe Research analyst Andy Chen has maintained their neutral stance on APLS stock, giving a Hold rating on November 3. Meet Your ETF AI Analyst Discover how Ti...
Apellis Pharmaceuticals ( (APLS) ) has released its Q3 earnings. Here is a breakdown of the information Apellis Pharmaceuticals presented to its investors. Elev...